Arkolith/Insider Trading/CERS/Form 4/A

Benjamin Richard J

Chief Medical OfficerCERUS CORP (CERS) · full profile →Form 4/A · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$251K
Net Open-Market Flow
-$251K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Sell(S)40K$1.88$76K879K
Mar 6, 2026Sell(S)24K$2.01$49K920K
Mar 5, 2026Grant(A)55K—$01.0M
Mar 5, 2026Sell(S)61K$2.06$126K944K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001296322-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML